Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what falsifiable science actually supports before you trust the answer.

Press Enter ↡ to search evidence


     Quick Explanation



    Lovastatin potently inhibits proliferation of two ER-negative breast cancer cell lines via isoprenoid depletion (mevalonate/GGPP rescue of 92–98%), disrupting RhoA, E2F1/Rb, and AKT signaling while suppressing glycolysis, TCA cycle activity, and lipid biosynthesis . However, it remains an in vitro study of only two cell lines with unvalidated clinical extrapolation.


     Long Explanation



    Core Mechanism: Isoprenoid Depletion Drives Antiproliferative Effects

    The study's strongest evidence comes from rescue experiments: co-exposure with mevalonate or GGPP restored proliferation to 92–98% of control, while FPP only partially rescued (67%), pinpointing geranylgeranylationβ€”not farnesylationβ€”as the critical mechanism . IC50 values (acid: 5–8 ΞΌg/mL; lactone: 7–9 ΞΌg/mL) are modestβ€”20 ΞΌM lovastatin/24h approaches clinically achievable exposures per an ovarian cancer parallel study .

    Proteomic and Metabolic Signature

    2D-GE proteomics (n=4/group) identified 74 changed proteins in MDAMB231 and 42 in MDAMB468, validated by Western blot. Key hits: GDI-2 up (stabilizing inactive RhoA), membrane-bound RhoA down (acid > lactone), MCM7 to 28% of control, MSH2 down, prohibitin up, PTEN up/DJ-1 down/pAkt down/NDRG1 up . NMR metabonomics (n=3) showed dramatic metabolic collapse in MDAMB468:

    Critical Appraisal and Blind Spots

    Strengths: Dual orthogonal platforms (proteomics + NMR metabonomics) cross-validate; rescue experiments are mechanistically decisive; directionality is coherent across all three signaling axes.

    Weaknesses: Only two ER-negative lines studiedβ€”no ER-positive, normal breast, or in vivo validation. Metabonomics was performed only in MDAMB468, not in the more sensitive MDAMB231, creating a cell-line asymmetry in the integrated dataset . The 2D-GE platform has limited dynamic range and misses low-abundance and heavily modified proteins. The mechanistic link between DJ-1 regulation and pAkt suppression is explicitly speculativeβ€”authors call it a hypothesis requiring further evaluation. Findings in cardiomyocytes show lovastatin causes both mevalonate-dependent apoptosis AND mevalonate-independent oncosis , raising the possibility that some observed breast cancer effects also involve mevalonate-independent mechanisms the paper does not test. Additionally, later TNBC work found lovastatin IC50 of 7.97 ΞΌM (MDA-MB-231) consistent with this paper, but linked the effect to MNRR1 inhibitionβ€”another mechanism this 2010 study could not have detected .

    What would change this conclusion: Failure of mevalonate/GGPP to rescue in a broader panel, absence of RhoA/GDI-2 changes on independent validation, or null in vivo xenograft results would falsify the central mechanism. No raw proteomics data deposition was described, limiting independent reanalysis.



    Feedback:    

    Updated: November 17, 2026



     BGPT Paper Review



    Study Novelty

    70%

    First combined 2D-GE proteomics + NMR metabonomics dissection of lovastatin in ER-negative breast cancer; identified GDI-2/DJ-1/SCP-2 as novel lovastatin targets within a well-precedented mevalonate mechanism.



    Scientific Quality

    70%

    Well-controlled, orthogonal validation, clear statistics; but only two cell lines, 2D-GE's limited dynamic range, no raw data deposition, metabonomics asymmetry across lines, and no in vivo work cap quality.



    Study Generality

    60%

    Findings apply to two ER-negative TNBC lines; PTEN/Rb-status dependence suggests generality across breast subtypes is untested.



    Study Usefulness

    70%

    Provides a mechanistic map for statin repurposing in TNBC and biomarker candidates (DJ-1, NDRG1, GDI-2); guides combination therapy design.



    Study Reproducibility

    60%

    Detailed methods and reagents listed; no raw dataset deposition described; Western blot and 2D-GE protocols are replicable from the text.



    Explanatory Depth

    70%

    Connects upstream isoprenoid depletion to specific signaling axes and metabolite flux changes; several causal links (DJ-1β†’pAkt) remain explicitly hypothesized.


    🎁 Authors: Collect 172 Free Science Tokens (β‰ˆ $17.2 USD)

    Claim My Author Tokens

    Use for 43 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $17.2 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    Statins kill cancer cells purely via cholesterol depletion β€” falsified here and elsewhere because mevalonate/GGPP (not cholesterol) fully rescues proliferation.


    All statin cytotoxicity is mevalonate-dependent β€” contradicted by cardiomyocyte oncosis that resists mevalonate rescue, suggesting partial non-HMGCR mechanisms may also operate in cancer cells.

     Science Art


    Paper Review: Effects of lovastatin on breast cancer cells: a proteo-metabonomic study Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($64 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT